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Abstract 
Lactobacilli colonize the human vagina and acidify it with lactic acid. In this highly acidic 
environment Lactobacilli manage to achieve a sparse, but near monomicrobial community, in 
which very few other species of bacteria are present. Despite the acidity of the vaginal 
environment, I have found that vaginal Lactobacilli grow optimally at a near neutral pH in 
cervicovaginal fluid (CVF) or culture media. Even when directly exposed to the acidity of the 
vagina, however, I observed ex vivo that the Lactobacilli are still growing and producing lactic 
acid at a slow rate. Women who do not have a monomicrobial community of Lactobacilli, have 
a polymicrobial community made up of many different gram-negative bacteria. Using ex vivo 
conditions I determined that vaginal lactic acid was sufficient to inactivate bacteria from the 
polymicrobial vaginal communities, precluding the necessity of peroxide production or 
bacteriocins, which have been previously suggested. Therefore, by maintaining high vaginal 
acidity, even at a slowed growth rate, Lactobacilli can protect the vagina against other 
communities of bacteria. Mild acidification beyond the stable pH attained by Lactobacilli in vivo, 
however, inactivated the Lactobacilli themselves. For the vaginal pH to remain stable and above 
what is fatal to the Lactobacilli, it requires a model in which lactic acid is lost from the vagina at 
the same rate as which the bacteria produce it, and where the rate the bacteria grow and 
adhere to the epithelium matches the rate of vaginal epithelial cell shedding. The majority of 
women worldwide have a polymicrobial community of vaginal bacteria, putting them at a 
higher risk for the acquisition and transmission of sexually transmitted infections, and poor 
birth outcome. For unknown reasons this risk also extends to women with specific Lactobacilli 
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spp. By measuring the vaginal acidity across different community state types I found that the 
higher risk Lactobacilli community (CST III-INERS) was correlated with less vaginal acidity. 
Therefore, the difference in risk between different bacterial communities is likely due to a 
difference in vaginal acidity. Vaginal acidity may inactivate pathogens outright, or protect a 
Lactobacilli dominated community by inactivating bacteria from polymicrobial vaginal 
communities. Even women with high vaginal acidity, however, have been observed to 
occasionally transition to a polymicrobial community. This suggests that other mechanisms 
must exist to determine which bacterial communities can remain in the vagina. Few studies 
have attempted to determine if the mucosal immune system plays a role in maintenance of 
vaginal bacteria communities, and of these studies none of have reported on host-antibody 
coating of vaginal bacteria, despite the important role it plays in the maintenance of gut 
bacteria. Using both microscopy and flow cytometry approaches I report antibody coating of 
vaginal Lactobacilli. Each method revealed extensive coating with IgG and IgA. A subset of the 
cultured bacteria from a CVF sample could be recoated with host antibodies from the CVF 
supernatant, suggesting some antibody specificity, and a potential role for the mucosal immune 
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Introduction: Lactobacilli dominated and polymicrobial 
vaginal communities 
The discovery of vaginal Lactobacilli and polymicrobial vaginal bacterial communities 
In 1892 German gynecologist Albert Döderlein published his discovery of gram-positive 
rod-shaped lactic acid producing bacteria in the vagina (Döderlein, 1892). He named the 
bacteria “Döderlein’s bacillus” and predicted that the production of lactic acid was crucial for 
protecting the vagina against bacterial infections, such as the “abnormal” bacteria observed in 
women who did not have “Döderlein’s bacillus” (Rogosa and Sharpe, 1960). “Döderlein’s 
bacillus” was soon determined to be Lactobacilli spp. and today the “abnormal” gram-positive 
bacteria can be clinically described as Bacterial Vaginosis (BV).  
Neither of these vaginal bacterial community types are present in prepubescent girls 
(except for a transient colonization in newborns elicited by maternal estrogen), or post-
menopausal women (Cruickshank, 1934; Cruickshank and Sharman, 1934; Farage and Maibach, 
2006). Instead, during these periods of low estrogen vaginal bacterial communities consist of a 
low concentration of various gram-positive bacteria. Vaginal communities dominated by 
Lactobacilli spp. and polymicrobial communities, arise after puberty due to estrogen-initiated 
deposition of glycogen in the vaginal epithelium. Despite the abundant supply of glucose due to 
host amylases depolymerizing glycogen (Spear et al., 2014), it is remarkable that some women 
have sparse Lactobacilli spp. dominated communities that are far less dense than the 
polymicrobial communities. 
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The prevalence of polymicrobial vaginal bacterial communities 
For the past 25 years, vaginal communities have been characterized with Nugent scoring 
based on bacterial morphotypes (Nugent et al., 1991). A meta-analysis of BV prevalence studies 
reported that the prevalence of BV in American sample sets ranged 19.3-29.2% (Kenyon et al., 
2013). Importantly, white women were less likely to be diagnosed as having BV (14-24.7%) 
compared to black women (25.8-51.4%), with Hispanic women tending to fall in between. 
Prevalence studies in other countries indicate BV prevalence correlates with the fraction of the 
population with African descent. Attempts to remove socioeconomic factors as confounding 
variables do not diminish the higher risk of having BV for being black (Koumans et al., 2007; 
Ness et al., 2003). However, the methodology involved in correcting for socioeconomic factors 
remains insufficient (Williams et al., 2010), and until better methodologies are put forward, 
care should be taken to avoid identifying being black as a causal agent of BV. 
Although roughly one-third of women were shown to have BV in the United States by 
Nugent scoring, only another one-third of women were predicted to have a vaginal bacterial 
community dominated by Lactobacilli spp. (Koumans et al., 2007). The remaining women are 
categorized as “intermediate” under Nugent scoring, and traditionally the label of “BV” is not 
extended to these women. The utility of distinguishing between “BV” and “intermediate” 
seems less important in the light of 16S community sequencing, which has not revealed 
bacterial community types that are specific to either “BV” or “intermediate” and not the other 
(Ravel et al., 2011). Instead, both types can be characterized as polymicrobial communities 
lacking a predominant Lactobacilli spp. Therefore, in this thesis polymicrobial communities will 
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refer to both “BV” and “intermediate” diagnoses by Nugent score, unless otherwise specified. 
Combining the prevalence of “BV” with the prevalence of “intermediate” reveals that roughly 
two-thirds of women have a polymicrobial vaginal bacterial community, and only a minority 
have lactobacillus-dominated communities. 
Risks associated with a polymicrobial vaginal bacterial community 
 Significant risks are associated with polymicrobial vaginal communities. Although many 
risk studies have focused only on women with a “BV” diagnosis, the extension of inclusion to 
any women with a polymicrobial vaginal bacterial community has revealed similar risk, 
validating our choice to distinguish only between polymicrobial communities and Lactobacilli 
dominated communities. 
 The risk factors associated with a polymicrobial community fall primarily into two 
categories: 1) Risk of acquisition, and transmission, of sexually transmitted infections (STIs), 2) 
Birth complications. A meta-analysis of the risk of HIV acquisition has reported that women 
with BV are 60% more likely to contract HIV than other women (Atashili et al., 2008). 
Importantly, studies grouping together any polymicrobial community reveal an association 
between HIV infection and polymicrobial communities (Cohen et al., 1995; Martin et al., 1999). 
Women with a polymicrobial community are also more likely to transmit HIV to their male 
partners (Cohen et al., 2012), potentially due to increased shedding of active virus in women 
with BV (Sha et al., 2005). A polymicrobial community is also more likely associated with, or 
puts a woman at elevated risk for trichomonal, gonococcal, and chlamydial infections (Brotman 
et al., 2010a; Martin et al., 1999; Wiesenfeld et al., 2003). 
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 Meta-analysis reveals that women with BV are more likely to experience miscarriage or 
preterm birth, especially if the BV is detected during early pregnancy (Leitich et al., 2003). More 
recent evidence using 16S sequencing has established that preterm birth is associated with not 
just BV but any polymicrobial community (DiGiulio et al., 2015; Hyman et al., 2014). There is a 
clear association between a polymicrobial community and pelvic inflammatory disease (PID), 
but a causal relationship has not yet been established (Taylor et al., 2013). 
 Treatment of BV remains a difficult task as is discussed further below. Without a clear 
treatment it remains very difficult to convincingly establish strong causal relationships between 
a polymicrobial community and its associated risks. With nearly two-thirds of women at an 
elevated risk for STI transmission and acquisition and poor birth outcome, it is paramount to 
find a way to treat polymicrobial communities or introduce a Lactobacilli dominated 
community, both to better establish causal relationships between a polymicrobial community 
and associated risks and likely to prevent them. 
The etiology of polymicrobial vaginal bacterial communities 
The etiology of a polymicrobial community is poorly understood. Many risk factors have 
been associated with BV prevalence including smoking (Brotman et al., 2014; Cherpes et al., 
2008; Hellberg et al., 2000), douching (Brotman et al., 2008; Holzman et al., 2001; Ness et al., 
2002), stress (Nansel et al., 2006) and sex practices including multiple male partners, a recent 
change in male partners, not using a condom or a recent female partner (Fethers et al., 2008), 
uncircumcised male partners or rectal sex before vaginal sex (Cherpes et al., 2008) and the use 
of lubricants (Brotman et al., 2010b).  
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Given the association of certain sex practices with BV it is possible that BV is 
transmissible between partners. Uncircumcised male partners of women with BV are more 
likely to have penile bacterial communities that include BV bacterial species (Liu et al., 2015) 
and one instance of suspected male to female transmission has been reported (Muzny and 
Schwebke, 2014). Treating male partners with antibiotics, however, has not been effective for 
preventing recurrent BV (Amaya-Guio et al., 2016; Mehta, 2012), suggesting that transmission 
from male partners does not explain many cases of recurrent BV. Amongst women who have 
sex with women (WSW) high concordance is observed in the vaginal bacterial community of 
partners (Evans et al., 2007; Marrazzo et al., 2002; Vodstrcil et al., 2014). This suggests that BV 
and/or Lactobacilli are being transmitted between partners. Interestingly, although these and 
other studies have reported female sex partners as a risk factor for BV (Koumans et al., 2007), 
analyzing sexual practices amongst WSW found a much higher risk of BV in WSW that used 
lubricants than those that did not (Marrazzo et al., 2010). This suggests that cases of 
concordant polymicrobial communities could be the result of shared sex practices which either 
cause a polymicrobial community to arise separately in each individual, or increase the chance 
of one partner with a polymicrobial community to transmit it to the other. 
The large number of risk factors associated with a polymicrobial community despite an 
inability to prevent recurrent BV by a single intervention suggests that acquisition is a 
multivariable event. It is very likely that different women obtain their vaginal community in 
different ways. Furthermore, initial exposure or transition to a polymicrobial community is 
likely mechanistically different than recurrence. Unlike Lactobacilli which maintain both a 
sparse concentration of bacteria and space between individual bacteria, BV bacteria form 
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extensive dense biofilms. Therefore, factors that cause BV may not be relevant to transmission, 
but to giving a fitness advantage to residual BV bacterial biofilms. 
The failure of antibiotic treatment and recurrent BV 
 Treating BV, especially recurrent BV remains a daunting task. Currently, the standard of 
care for symptomatic BV is antibiotic treatment, typically metronidazole or clindamycin 
(Centers for Disease Control and Prevention, 2015). Antibiotic treatment of BV has a high short-
term cure rate—80-90% after one week of treatment (Larsson, 1992)—but relapse occurs 
frequently. Many studies have identified recurrence as early as one month after treatment 
(Bradshaw et al., 2006; Sobel et al., 1993), and agree that after a year the majority of women 
will have had a recurrent episode of BV (Boris et al., 1997; Bradshaw et al., 2006). In these 
studies, sexual practices, including new sexual partners were most highly associated with 
recurrence.  
Probiotic approaches to treating BV 
 For nearly two decades vaginal probiotics have been explored to improve the low 
efficacy of antibiotics to prevent recurrent BV. Unfortunately, the majority of these approaches 
have had mixed results. Three large meta-analyses of vaginal probiotic trials found no 
conclusive evidence that using vaginal probiotics prevents recurrent bacteria (Falagas et al., 
2007; Homayouni et al., 2014; Senok et al., 2009). Some trials are more successful than others, 
but most of these trials do not treat transition to a bacterial community dominated by 
Lactobacilli spp. as the positive outcome, instead relying on overly sensitive detection methods 
of any Lactobacilli spp., or an indirect diagnosis of BV such as Amsel’s criteria. 
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 An efficacious vaginal probiotic remains a high priority in the field given the failure of 
antibiotics to prevent recurrent BV. It remains unclear why vaginal probiotic attempts have 
failed, but it is likely that the vaginal environment and the state of the bacteria in the probiotic 
are not compatible. Therefore, in order to one day create a better probiotic, we need to 
understand the basic biology of how Lactobacilli maintain themselves, and dominate the 
vaginal environment. 
Vaginal Lactobacilli acidify the vagina with lactic acid 
Even in 1892, Döderlein predicted that vaginal lactic acid was the key to the prevention 
of “abnormal” bacterial communities. Experiments by our lab were the first to measure both 
the degree of acidity in cervicovaginal fluid (CVF) from individuals with a Lactobacilli-dominated 
vaginal community, and to establish that the Lactobacilli were the source of such acidity. 
Original measurements of vaginal pH were highly variable and failed to exclude individuals with 
a polymicrobial vaginal community (Cohen, 1969; Hunter and Long, 1958). A more 
contemporary review of vaginal pH measurements reported an average pH of 4.2 for women 
with a Lactobacilli dominated community (Owen and Katz, 1999). With the advent of Nugent 
scoring our lab was able to make pH measurements in CVF obtained from individuals with 
Lactobacilli dominated vaginal communities. Under standard laboratory conditions we found 
that the pH of CVF in these individuals was 3.74 (O’Hanlon et al., 2013). However, measuring 
the pH of CVF outside the vaginal environment does not take into effect alkalinizing effect of 
the loss of carbon dioxide on aerobic exposure. Measuring the pH of CVF under 5% CO2 
confirmed this concern, yielding an average pH of 3.48. A second study was performed, 
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measuring the vaginal pH directly with a vaginally inserted pH electrode and confirmed the 
accuracy of the in vitro method under 5% CO2. These studies establish that the acidity of the 
Lactobacilli dominated vagina is significantly lower than previously thought. The acidity of the 
vagina is surpassed only by that of the stomach, adding intrigue to the mechanisms by which 
Lactobacilli themselves are able to survive and thrive. 
The chemical nature of lactic acid allowed our lab to determine that vaginal acidity must 
be produced by the vaginal bacteria and not the host. Lactic acid is a chiral molecule, typically 
produced by stereoisomer specific lactate dehydrogenases to replenish NADH through the 
conversion of NAD+. Although humans lack the D-lactate dehydrogenase enzyme, we found that 
many vaginal samples contained high concentrations of D-lactate (Boskey et al., 2001). This 
suggested a bacterial source for D-lactate. Moreover, culturing the vaginal samples in growth 
medium resulted in cultures with a similar D:L ratio to that of the original CVF, confirming that 
the majority of vaginal lactic acid is produced by Lactobacilli.  
The lactic acid concentration of CVF is tightly inversely correlated to the pH in 
Lactobacilli dominated samples (O’Hanlon et al., 2013). Since the Lactobacilli are the source of 
the lactic acid, this suggests that vaginal pH is also determined by the bacteria, and not by the 
host. Corroborating this hypothesis, we found that cultures of vaginal Lactobacilli not only 
reach the D:L ratio of the original CVF, but the final pH directly correlates as well—more acidic 
cultures arise from more acidic vaginal samples (Boskey et al., 1999). Not only are the bacteria 
the source of vaginal acidity, but there must be differences within the strains of bacteria that 
cause higher or lower levels of lactic acid, and therefore pH. This is the subject of Chapter 2. 
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Lactic acid is a potent microbicide 
Amongst women who have vaginal Lactobacilli, BV is more frequently associated with strains of 
Lactobacilli that do not produce H2O2 (Cherpes et al., 2008; Eschenbach et al., 1989). 
Furthermore, amongst women with a Lactobacilli dominated vaginal bacterial community, the 
risk of STI acquisition is lower if the Lactobacilli produce H2O2. This raised the plausible 
hypothesis that H2O2 produced by lactobacilli is responsible for inactivating BV associated 
bacteria and vaginal pathogens. Although high concentrations of H2O2 producing Lactobacilli 
were toxic to BV bacteria in vitro while non-H2O2 producing Lactobacilli were not, the effect was 
abolished by raising the pH (Klebanoff et al., 1991).  
 Using lactic acid solutions as well as cell-free CVF samples from women with Lactobacilli 
dominated communities, our lab demonstrated that lactic acid was important for the 
inactivation of BV-associated bacteria in vitro and not H2O2 (O’Hanlon et al., 2011). H2O2 
solutions were microbicidal to BV-associated bacteria, however, a minor addition of cell-free 
CVF completely abolished the inactivation, likely due to the high antioxidant properties of CVF. 
Importantly, the microbicidal activity of lactic acid was abolished at a neutral pH, and an acidic 
pH without lactic acid was not nearly as effective. This suggests that the protonated form of 
lactic acid is important for inactivation. Aside from BV-associated bacteria, lactic acid is capable 
of inactivating HIV (Aldunate et al., 2013), Chlamydia trachomatis (Gong et al., 2014) and HSV 
(Conti et al., 2009). Therefore, many of the risks associated with a polymicrobial community are 
most likely due to the lack of lactic acid. This subject is addressed in Chapter 3. 
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The unexplored role of the mucosal immune system in regulating vaginal bacterial 
communities. 
 Despite extensive studies of the role of the mucosal immune system in regulating GI 
tract microbiota, no studies to date have examined its role in the vagina. As a first step in 
beginning this exploration, Chapter 4 reports that healthy, non-inflammatory vaginal lactobacilli 
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How vaginal Lactobacilli regulate the vaginal pH 
Chapter abstract 
Lactobacilli colonize the human vagina and acidify it with lactic acid. What has remained 
unclear is how vaginal Lactobacilli regulate the pH of the vagina and whether the lactic acid 
they produce is sufficient for them to dominate the vaginal bacterial community. Here I report 
that in ex vivo cultures as well in vitro cultures of cervicovaginal fluid CVF, the growth rate of 
vaginal Lactobacilli slows as they approach vaginal pH. At vaginal pH the replication rate of 
Lactobacilli must match the rate at which these bacteria are shed from the vagina by the rapid 
shedding of vaginal epithelial cells. Also, at this growth rate Lactobacilli must produce lactic acid 
at the same rate it leaves the vagina; it is this steady state of growth rate and lactic acid 
production rate that determines the pH of the vagina. I find that at this acidic pH the 
concentration of lactic acid is a broad-acting and potent microbicide sufficient to inactivate 
polymicrobial communities in ex vivo CVF samples from individuals with Bacterial Vaginosis 
(BV). Lactobacilli are close to killing themselves with this lactic acid acidity: In ex vivo cultures, 
modest over-acidification, and/or modest addition of lactic acid at vaginal pH speeds the death 
of vaginal lactobacilli. In regulating the steady-state of vaginal pH, the permeability of the 
vaginal epithelium to lactic acid, and the shedding rate of vaginal epithelial cells are important 
host factors that likely determine the strains of lactobacilli that can maintain dominance over 




Vaginal Lactobacilli determine the acidity of the vagina through the production of lactic acid 
Over a century ago, Döderlein proposed that the healthy human vagina is acidified by 
bacteria (Döderlein, 1892). His hypothesis was based on his discovery of lactic acid producing 
bacteria, later identified as Lactobacilli, within the vagina that were not present in women who 
did not have acidic cervicovaginal fluid (CVF). Over the years the degree to which Lactobacilli 
were responsible for determining the vaginal acidity was contested. An alternate source of 
lactic acid is from epithelial cell metabolism in the hypoxic environment of the vagina. Others 
acknowledged the role of Lactobacilli in acidifying the vagina, but believed the presence of BV 
bacteria could produce alkalizing agents and raise the pH (Pybus and Onderdonk, 1999).  
Our lab determined that Lactobacilli are sufficient to explain vaginal acidity. The pH of 
the vagina varies between women, and correlates strongly with the asymptotic pH to which 
vaginal Lactobacilli acidify their growth medium (Boskey et al., 1999). More convincingly, 
different species and strains of vaginal Lactobacilli produce different ratios of the optical 
isomers of lactic acid, and cultures of vaginal Lactobacilli produce D:L ratios of lactic acid that 
correlate strongly with the D:L ratio in the cervicovaginal fluid (CVF) from which they are 
obtained (Boskey et al., 2001). In particular, when strains of Lactobacillus crispatus dominate 
the vaginal microbiota, they produce more D than L isomers and the high D:L ratios strongly 
correlate between cultured CVF and the CVF itself (Witkin et al., 2013). In contrast, human 
metabolism can only produce the L isomer. Although these approaches do not rule out the 
vaginal epithelium as a source of lactic acid, it suggests that the amount being produced is not 
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enough to influence the vaginal pH compared to the amount being produced by Lactobacilli. If 
Lactobacilli determine the acidity of the vagina, they also must regulate it. 
The pH of the vagina is stably acidic, despite Lactobacilli spp. preferring a neutral 
environment 
Vaginal Lactobacilli acidify the vagina to pH 3.6 on average with a lactic acid 
concentration around 110 mM when they are the predominant species in the vaginal bacterial 
community (O’Hanlon et al., 2013). This environment is unique both within the human body, 
where only the stomach is more acidic, and amongst other mammals. Humans remain the only 
primates in which Lactobacilli spp. have been found to predominate the vaginal bacterial 
community (Stumpf et al., 2013). 
Although capable of acidifying their environment, the optimal growth of non-vaginal 
species of Lactobacilli such as L. delbruekii, L. acidophilus, and L. paracasei occurs at near 
neutral pH (Adamberg, 2003). Acidification of the growth media through the production of 
lactic acid beyond the optimal pH slows the rate of growth in these strains. This problem has 
been well understood in the food industry. To maximize the concentration of bacteria, 
Lactobacilli starters are grown in pH-controlled bioreactors (Rault et al., 2009). By holding the 
pH stable the population can continue to grow at its optimal rate. Recently, we recorded 
vaginal pH in vivo with intravaginal electrodes, and found the pH to be very stable, remaining 
within 0.1 pH units over 90 or 45 min intervals (O’Hanlon, in submission). To achieve stable 
acidic conditions in the vagina, vaginal Lactobacilli must continue to grow, replicate and 
produce lactic acid at rates that equal the loss of bacteria and the loss of lactic acid from the 
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vagina. Unlike non-vaginal strains of Lactobacilli, vaginal strains might grow optimally at the low 
pH values observed in CVF. However, one of the only studies that looked at the effect of initial 
culture pH on the growth of a vaginal species of Lactobacilli used an ATCC strain of L. gasseri 
and observed a decreased growth rate at pH 4 compared to 5 or 6 (Boskey et al., 1999). 
Alternatively, vaginal Lactobacilli are maintaining a non-optimal environment in regards to 
growth. 
Bacterial acid adaptations 
Another possibility, is that to continue growing at a rapid enough rate, vaginal 
Lactobacilli might minimize their exposure to the acidity. Helicobacter pylori despite colonizing 
the human stomach is well adapted to minimize its exposure to the highly acidic stomach acid. 
Similar to Lactobacilli spp., H. pylori grows optimally between 5.5 and 8.5 (Morgan et al., 1987; 
Scott et al., 1998) and is actually inactivated if exposed to pH values below 3.5 due to a collapse 
of its transmembrane potential difference (Meyer-Rosberg et al., 1996). The ability of H. pylori 
to survive in vivo is thought to depend on its chemotactic motility to penetrate the gastric 
mucus layer to reach the less acidic pH near the epithelium (Schreiber et al., 2004). If vaginal 
Lactobacilli use a similar strategy, Lactobacilli suspended in the vaginal lumen should be dead or 
dying, and only those residing at a higher pH, perhaps deep within the epithelium, would grow 
and produce lactic acid.  
Although it is possible that Lactobacilli spp. and H. pylori use similar mechanisms, there 
are also many differences between the two bacteria. In the case of H. pylori the source of the 
acid is the gastric epithelium, and the highest acidity is achieved away from the epithelium and 
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the mucin layer, likely due to viscous fingering (Bhaskar et al., 1992). Lactobacilli themselves are 
the source of the acid, suggesting it would be more difficult for them to avoid exposure. H. 
pylori also releases the enzyme urease into its periplasmic space. Cleavage of urea results in 
two molecules of the proton-acceptor NH3 thus increasing the pH within the periplasmic space 
(Bode et al., 1993; Scott et al., 1998). Due to the activity of urease, adding urea is sufficient to 
prevent the transmembrane potential difference collapse observed below pH 3.5 (Meyer-
Rosberg et al., 1996). Lactobacilli, however, are gram-positive lacking a periplasmic space, and 
have not been shown to release pH altering molecules, other than lactic acid itself. 
Lactic acid is a potent microbicide 
Although the production of lactic acid may slow the growth rate of vaginal Lactobacilli, it 
may also provide a selective advantage. Polymicrobial vaginal communities tend to fluctuate 
rapidly with one or more episodes of BV per month while the monomicrobial Lactobacilli 
communities tend to be stable over months to years (Brotman et al., 2010; Gajer et al., 2012). 
The stability of these communities may be due to the microbicidal actions of lactic acid at an 
acidic pH. Lactic acid is a potent and broadly active microbicide that provides significant 
protection to women with a vaginal bacterial community dominated by Lactobacilli spp. We 
and others have found that the vaginal concentration of lactic acid inactivates HIV (Aldunate et 
al., 2013), Chlamydia trachomatis (Gong et al., 2014) and HSV (Conti et al., 2009). In these 
studies the microbicidal activity of lactic acid was abolished at a neutral pH, however, an acidic 
pH without lactic acid was not as effective. Furthermore, the L-isomer of lactic acid was more 
potent for inactivating HIV while the D-isomer was more potent for inactivating Chlamydia 
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trachomatis. Taken together, these results suggest that the protonated form of lactic acid is 
microbicidal, but also that the structure of the molecule is important. 
We have also shown in vitro that vaginal concentrations of lactic acid potently kill 
isolates of 17 species of BV-associated bacteria (O’Hanlon et al., 2011). Therefore, it may be 
lactic acid that prevents transitioning from a vaginal bacterial community dominated by 
Lactobacilli spp. to a polymicrobial community. Despite the strong microbicidal activity 
observed in this study in vitro, it is essential to show that effect can also be observed ex vivo. 
Bacteriocins represent an alternative hypothesis to lactic acid as to how Lactobacilli may 
prevent the growth and vaginal colonization of BV bacteria. Several bacteriocins are produced 
by specific Lactobacilli spp. that exhibit bacteriocidal effects against G. vaginalis, a key BV-
associated bacterial species (Stoyancheva et al., 2014). However, these tests were only 
performed at a neutral pH and bacteriocins may be unnecessary for the inactivation of BV 
bacteria in the presence of a high concentration of lactic acid. 
Not only are vaginal bacterial communities dominated by Lactobacilli spp. near 
monomicrobial, but the each tends to consist of a single species and possibly strain of vaginal 
Lactobacilli. One explanation for this phenomenon may be that Lactobacilli themselves can be 
inactivated if the acidity drops below a certain point. If numerous strains of Lactobacilli were 






I: Do vaginal Lactobacilli continue to grow and acidify under the acidic conditions of the 
vagina? 
To understand how vaginal Lactobacilli continue to dominate the vaginal bacterial 
community, and maintain a stable vaginal pH, I wanted to determine if vaginal Lactobacilli could 
be observed growing and acidifying ex vivo at the in vivo vaginal pH. Samples obtained ex vivo 
by inserting and removing a softcup contain mostly luminal bacteria, as well as some bacteria 
bound to the outer layer of the vaginal epithelial cells that were scraped off. Observing whether 
this population of bacteria was growing was important to determine if vaginal Lactobacilli could 
tolerate and continue to grow directly in its acidic environment, unlike H. pylori, or if the 
growing population was sequestered deeper in the vaginal epithelium. 
II: Does overacidification of CVF lead to the inactivation of Lactobacilli? 
 At high vaginal concentrations of lactic acid the bacterial community is near 
monomicrobial, usually comprising a single Lactobacilli spp. This likely occurs as a strain of 
Lactobacilli achieve stable vaginal acidity that inactivates all other bacteria until this dominant 
strain is all that remains. I wanted to understand what happens to these Lactobacilli if the 
vaginal acidity increases beyond what they were exposed to in vivo. Knowing if vaginal 
Lactobacilli are inactivated by overacidification is important for understanding both the 
mechanism by which vaginal Lactobacilli reach a stable asymptotic vaginal pH, as well as why 
vaginal Lactobacilli usually exist in a near monomicrobial community. 
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III: Is vaginal lactic acid sufficient to inactivate BV bacteria ex vivo? 
 Vaginal lactic acid is a potent microbicide and inactivates BV-associated bacteria in vitro. 
H2O2, however, was also shown to be a potent microbicide in vitro, but was not efficacious ex 
vivo. By obtaining BV bacteria ex vivo I wanted to verify the physiological significance of the 
microbicidal activity of lactic acid. Furthermore, although bacteriocins produced by vaginal 
Lactobacilli have been discovered, I believed that the acidity of the CVF due to lactic acid was 
sufficient to inactivate BV bacteria. By dialyzing CVF obtained from women with low Nugent 
scores against saline, I removed lactic acid from CVF. Using the original CVF and the dialyzed 

















Materials & Methods 
CVF Collection 
All CVF samples were self-collected by donors by inserting and removing an Instead® 
SoftCup menstrual collection device (Boskey et al., 2003). Softcups were placed in 50 mL conical 
tubes and centrifuged to collect the CVF. All samples were gram stained and observed under 
the microscope to assign a Nugent score (Nugent et al., 1991). In the majority of experiments 
only samples with Nugent score of 0-3 were used to ensure that the results reflected the 
behavior of vaginal Lactobacilli, and not a polymicrobial vaginal community. For the BV bacteria 
inactivation experiments only samples with a Nugent score of 7 or higher were used. 
CVF video microscopy and bacterial growth rate determination 
CVF was lightly applied to 10 uL 1.5% agarose pads which were then sealed in a slide 
chamber under anaerobic conditions. In some experiments, NaOH was added to alkalinize the 
pH of CVF to pH 6. Typically, the volume of NaOH was close to but no more than 1 tenth of the 
volume of the sample. Live bacteria were visualized on a Zeiss Axiovert 200 inverted light 
microscope using a DIC filter at 63x magnification within a temperature controlled chamber. 
The lengths of at least 30 bacterial chains were measured over a four hour period using 
ImageJ. By normalizing elongation rates to the original length of the chain, percent elongation 
rates were obtained, and converted to doubling times. A single average doubling time was 
calculated for each bacterial chain.  
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For planktonic growth experiments CVF samples were rinsed twice in a 10-fold volume 
of saline before being resuspended in MS growth medium of varying pH. Amphotericin B was 
added to the cultures to prevent fungal growth. Cultures were placed in a sealed 96-well plate 
and the OD600 was monitored over time at 37°C. Given that the pH of these cultures would not 
remain constant over time, only the initial rate of change in OD600 (between 0 and 6 hours) 
was measured. 
Measuring the lactic acid concentration and pH in CVF samples incubated over time 
Freshly obtained unmodified CVF was quickly exposed to a hypoxic environment in 
glove-box transferred to a single test tube, before being sealed and placed in a 37°C incubator. 
Over time the tube was removed from the incubator and its pH was determined using a 
microelectrode. To maintain the hypoxic environment, pH measurements were only performed 
within the glove-box. Aliquots of CVF were taken at each timepoint and frozen. Frozen samples 
were thawed and spun to obtain CVF supernatants from the various timepoints. The lactic acid 
concentration of these supernatants was measured using the D-lactic acid/L-lactic acid 
Enzymatic BioAnalysis/Food Analysis UV method kit (R-Biopharm, Darmstadt, Germany), and a 
plate spectrometer. Typically samples were diluted 1:30 for the signal to be in the linear range 
of the spectrometer. 
Bacterial inactivation assays 
Saline and lactic acid mixtures were added to fresh CVF in a 1:5 ratio before incubation 
at 37°C under hypoxic conditions. In samples where the pH was kept constant, the saline and 
lactic acid mixtures were titrated beforehand to match the pH of the sample. After two hours of 
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incubation the samples were diluted 1:10 in a 50 mM HEPES saline solution at pH 7. Samples 
were serially diluted w/v in saline then plated on Brucella broth, 5% sheep blood plates. Blood 
plates were chosen to ensure that most vaginal species of bacteria would be able to grow. 
Blood plates were incubated at 37°C in anaerobic jars with oxygen scavenger sachets. After 2-3 
days of incubation, CFUs were counted. 
CVF microdialysis 
CVF samples from women with low Nugent scores were somewhat diluted (1:10) to thin 
the mucus, and supernatants obtained by centrifugation were then sterile filtered using 0.2 
micron spin filters. Sterile CVF was pipetted into dialysis chambers and sealed with a square of 
2 kDa MWCO dialysis membrane. Chambers were floated on dialysate that was gently stirred 










Vaginal Lactobacilli species tolerate and continue growing at the vaginal pH 
Non-vaginal species of Lactobacilli including L. delbrueki, L. acidophilus, and L. paracasei 
optimally grow in culture at neutral or near-neutral pH (Adamberg, 2003). If vaginal Lactobacilli 
achieve a steady vaginal pH, but their growth is determined by the pH, vaginal Lactobacilli must 
continue to grow and acidify even while exposed to the acidity of CVF. To test this I directly 
observed ex vivo vaginal Lactobacilli growing in CVF. Using video microscopy I measured the 
doubling time of bacteria in unmodified CVF obtained from individuals with a Nugent score of 
0-3 (Fig 1A, images: Fig 2). Across all the samples it was estimated that at least 95% of the 
bacteria were elongating at a rate that doubled their length in about 12 hours. If the growth 
rate of vaginal bacteria is determined by the vaginal pH I would expect the doubling of ex vivo 
Lactobacilli in CVF to increase if the pH of the CVF was artificially raised. As expected raising the 
pH of CVF to 6 through the addition of NaOH shortened the doubling time of the bacteria. On 
average the doubling time was about 3-fold shorter in alkalinized CVF compared to unmodified 
CVF. This trend was also true if the CVF samples were cultured in media. I measured the growth 
rate of ex vivo vaginal bacteria in MS, a Lactobacilli-restrictive growth medium, at an initial pH 
between 4 and 6, using OD600. In each cultured sample the highest growth rate was observed 
in cultures with an initial pH of 6, and the lowest growth rate was observed in cultures with an 
initial pH of 4 (Fig 1B).  
Vaginal bacteria continue to acidify ex vivo 
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Lactic acid fermentation is necessary for Lactobacilli to produce energy. If the vaginal 
bacteria are still growing in the acidic environment of the vagina, they must continue to 
produce lactic acid. As expected, anaerobic incubation of CVF samples from women with 
Nugent scores 0-3, caused the pH to decrease over time, as the lactic acid concentration 
increased (Fig 3). On average the bacteria continued to produce lactic acid at a rate of 13 
mM/hr. Not surprisingly, an increase in the lactic acid concentration caused a decrease in the 
pH of the CVF, which can be observed over time. The pH ex vivo continues to drop, despite our 
previous finding that the in vivo CVF pH is stable. This suggests that the lactic acid being 
produced in vivo is lost from the vagina, likely by crossing the vaginal epithelium. 
Concentrations of lactic that exceed the vaginal pH can limit the growth or inactivate vaginal 
Lactobacilli 
Matching the rate of lactic acid production to the loss across the epithelium provides an 
explanation as to how a stable pH is achieved, however, it remains unclear why some strains 
reach a lower pH than others. At least two possibilities exist: 1) Host factors such as the 
shedding rate of the vaginal epithelium, or the permeability of the vaginal epithelium to lactic 
acid determines the stable vaginal pH; 2) Vaginal strains of Lactobacilli acidify as far as they are 
able without overly slowing their own growth rate or inactivating themselves. The second 
possibility is supported by our previous experiments. When we incubated CVF samples both the 
production of lactic acid, and the change in pH plateaued between 5 and 10 hours, suggesting 
eventual inactivation of the bacteria. Given that the vaginal Lactobacilli grow more slowly at an 
acidic pH, I wanted to test if additional lactic acid eventually caused inactivation. I increased the 
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lactic acid concentration of fresh CVF and measured the fraction of CFUs remaining after two 
hours of incubation at 37°C. In each sample, any additional lactic acid reduced the number of 
CFUs compared to incubation with saline (Fig 5). The high concentrations of lactic acid reduced 
the concentration of CFUs to less than were observed before incubation, suggesting that at 
these levels the bacteria were inactivated. I also increased the lactic acid concentration without 
lowering the pH by using lactic acid that had been titrated to match the pH of the sample. 
Similar inactivation was observed, suggesting that the concentration of weak acid, and not just 
the pH is important. 
Vaginal lactic acid is sufficient to kill BV-associated bacteria 
Lactic acid is a potent microbicide, and we and others have shown that vaginal levels 
can inactivate HIV (Aldunate et al., 2013), C. trachomatis (Gong et al., 2014) and HSV (Conti et 
al., 2009) as well as BV-associated bacteria in vitro (O’Hanlon et al., 2011). During the 
development of HIV microbicides for vaginal protection, many candidates that potently 
inactivated HIV in vitro, were strongly inactivated by CVF and/or semen, most notably in the 
case of H2O2. Therefore, I sought to determine whether lactic acid was effective against BV-
associated bacteria in the presence of CVF. Recent discoveries suggest that Lactobacilli 
produced bacteriocins play a role in fending off other bacteria (Stoyancheva et al., 2014), 
however, I believe that lactic acid is sufficient at the vaginal pH to inactivate BV bacteria. To test 
this I sterile-filtered CVF from women with Nugent scores 0-3 and performed dialysis across a 2 
kDa MWCO membrane. Dialysis against saline was successful in removing nearly 95% of the 
lactic acid. Incubation of ex vivo BV bacteria with the undialyzed CVF reduced the concentration 
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of CFUs by 100-fold on average, whereas no significant reduction in CFUs was observed if the 
CVF was dialyzed against saline (Fig 6). Many small molecules including lactic acid will be lost 
across a 2 kDa MWCO membrane. Therefore, to show that lactic acid alone, is sufficient to 
inactivate BV bacteria, I also dialyzed the CVF from low Nugent women against a saline solution 
with a matched lactic acid concentration to the original sample. The CVF that retained its lactic 
acid caused levels of inactivation that were not significantly different than the undialyzed CVF. 
This confirms that vaginal lactic acid is sufficient to inactivate BV-associated bacteria in CVF. To 
determine if the potency of lactic acid was only due to pH I also dialyzed against a saline 
solution that lacked lactic acid, but was matched to the pH of the original sample. The CVF that 







I have determined that the growth rate of vaginal Lactobacilli is dependent on the 
vaginal pH. This is in agreement with the ATCC strain of L. gasseri and other Lactobacilli spp. 
(Adamberg, 2003; Boskey et al., 1999). Furthermore, at the stable vaginal pH the Lactobacilli 
are still growing, albeit 3 times slower than if the vaginal pH was 6. This is in marked contrast to 
H. pylori which has adapted to avoid or counter the acidity of the stomach. Instead, Lactobacilli 
survive and grow while directly exposed to the acidity of the environment, which they produce.  
A possible reason for why Lactobacilli slow their growth rate is to divert more energy 
toward an acid-resisting response, however, our data suggests it also prevents vaginal 
Lactobacilli from creating an environment that is too harsh to survive. In each of our CVF 
samples an increase in the lactic acid concentration inhibited growth or caused bacterial 
inactivation regardless of the starting concentration or pH of the CVF. Too many Lactobacilli 
could acidify too quickly for the population to survive. This strongly suggests that the vaginal 
asymptotic pH is selected for as the lowest pH the bacteria can survive. Overall, it is likely 
beneficial for the vaginal Lactobacilli to create an environment that is just barely tolerable, but 
contains a high concentration of lactic acid. 
Here I report that lactic acid alone is sufficient to inactivate ex vivo BV bacteria in CVF. In 
agreement with the in vitro study from our lab (O’Hanlon et al., 2011), lactic acid at an acidic pH 
caused more inactivation of BV bacteria than an acidic pH alone. The in vitro study and ex vivo 
experiments presented here differ in the degree of bacterial inactivation. O’Hanlon reported 
inactivation between 4 and 5 log units, while only a 2 log unit inactivation was observed ex vivo. 
This could reflect differences between the ex vivo BV bacteria and the ATCC strains of BV-
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associated bacteria. Actual BV bacteria are more likely to have been challenged by Lactobacilli 
or lactic acid in the past, and may be more resistant. Furthermore, as all of these experiments 
took place in CVF, it is also possible that the high concentration of energy sources allowed BV 
bacteria to rapidly metabolize and defend themselves against lactic acid.  
Although lactic acid is sufficient to inactivate BV bacteria, this data does not rule out a 
role for vaginal Lactobacilli bacteriocins, but suggests they would be unnecessary at an acidic 
pH. Instead, they may be important during times of alkalization such as ejaculation or menses 
to fend off other bacteria. As most bacteriocins are species specific, it would make sense for 
Lactobacilli bacteriocins to play a specific role in the vagina, while lactic acid remains a broad-
spectrum microbicide. 
These results in total provide a model by which a steady-state vaginal pH is created and 
maintained by vaginal Lactobacilli. In response to neutralization, by either ejaculation or 
menses, the growth rate of vaginal bacteria would quickly increase, as was observed ex vivo 
with NaOH. Increasing the growth rate would likely increase the number of vaginal Lactobacilli 
and therefore the rate of acidification. As the vagina reacidifies the growth rate would begin to 
slow. If the rate of acidification remained too high, the pH would go below what the bacteria 
could tolerate and the growth rate would get too low to support the population. Less bacteria 
would lower the acidification rate until it matched the loss of acid across the vaginal epithelium, 
creating a steady-state population. 
This model is useful to understand a key observation of vaginal Lactobacilli. In most 
women only one species of Lactobacilli is present in high numbers. This would be expected 
given our model. If two species of Lactobacilli were present at first, the species that acidified to 
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and could survive the lower pH would eventually outnumber the other. In terms of Lactobacilli 
probiotic design, we would expect a vaginal strain with a low asymptotic pH to be more 
beneficial in preventing BV, and potentially more stable in the long-term due to its superior acid 
tolerance. 
An implication of this model is that the lowered growth rate of the bacteria at the 
asymptotic vaginal pH must also match the loss-rate of bacteria due to vaginal epithelium 
shedding. Some groups have claimed that the rate of vaginal epithelial shedding is faster in 
women with BV (Gilbert et al., 2013), however, data presented in the next chapter may 
contradict this. Interestingly, lubricant use is associated with episodes of BV in individuals with 
less stable vaginal populations. Most lubricants are hypertonic and cause excessive shedding of 
the vaginal epithelium (in preparation). This would be detrimental to a low pH, slow growing 
Lactobacilli population. A faster shedding rate could only accommodate a Lactobacilli 
population growing at a higher pH, and therefore growing faster.  
In the next chapter I present data that a vaginal community dominated by L. crispatus 
correlates with a lower pH than a vaginal community dominated by L. iners. Interestingly, L. 
iners samples have a higher concentration of bacteria than L. crispatus samples (unpublished 
observation), adding support to a connection between bacterial growth rates and the vaginal 
pH, and predicting that shedding rates are likely different as well. What remains unclear is if 
this is due to variable shedding rates between individuals, or if the shedding rates could be 
linked to the pH. One study has shown that increasing the pH of skin above 5 increases the 
shedding rate (Lambers et al., 2006), offering the possibility that Lactobacilli may lower the 
shedding rate through the production of lactic acid. Understanding the variability of epithelium 
35 




















Figure 1—The growth rate of vaginal Lactobacilli decreases as the pH decreases 
Doubling times of vaginal Lactobacilli in unmodified ex vivo CVF and CVF alkalinized to pH 6 as 
determined by video microscopy (A); Growth rate in titrated growth media as determined by 
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Figure 2—Video microscopy demonstrating the growth of vaginal Lactobacilli ex vivo 
Video microscopy of vaginal Lactobacilli incubated in unmodified ex vivo CVF (top) or CVF 
alkalinized with NaOH to pH 6 (bottom) demonstrating slow bacterial elongation at near vaginal 
pH and much more rapid elongation at pH 6. The arrows point to the position of one end of 
selected bacteria at t=0. 

















   
   
   
   
   
   




Figure 3—Incubated ex vivo vaginal Lactobacilli continue to produce lactic 
Concentration of lactic acid in unmodified ex vivo CVF obtained from donors with Nugent = 0-3 
incubated hypoxically at 37°C over time. Each line represents a unique donor. Dotted lines 






























Figure 4—The pH of unmodified ex vivo CVF decreases when incubated  
CVF obtained from donors with Nugent = 0-3 incubated hypoxically at 37°C over time. Each line 
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Figure 5—Additional lactic acid beyond the in vivo concentration inactivates vaginal 
Lactobacilli 
Log of the fraction of CFUs remaining after the addition of lactic acid to fresh CVF and 2 hours 
of incubation at 37°C, as compared to adding only saline. t=0 refers to the initial fraction of 
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Figure 6—Lactic acid is sufficient to inactivate BV bacteria ex vivo  
Log of the fraction of CFUs after incubation of ex vivo BV bacteria with dialyzed CVF from low 
Nugent individuals compared to saline. CVF was either left undialyzed or was dialyzed against 
saline, saline with the same pH and lactic acid concentration as the undialyzed CVF and saline 
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Vaginal acidity and physiology as a function of specific 
bacterial communities 
Chapter abstract 
The vaginal microbiota falls into one of two major groups: near monomicrobial Lactobacillus 
species, or polymicrobial communities. Epidemiological studies have shown that women who 
lack a predominant Lactobacilli species are at a higher risk for STI transmission. Interestingly, 
even amongst women with a predominant Lactobacilli species, there’s a higher risk associated 
with Lactobacilli spp. that do not produce H2O2, compared to those that do. Community 
sequencing has revealed that amongst women with a predominant Lactobacilli spp., the vaginal 
microbiota comprises three community state types (CSTs), each defined by a specific species of 
Lactobacilli spp. Polymicrobial communities, which manifest clinically as Bacterial Vaginosis (BV) 
comprise two CSTs, each of which lack the predominance of Lactobacilli spp. We have 
previously established that H2O2 is not the microbicidal agent in CVF. Instead, lactic acid and a 
low pH allow for the inactivation of HIV and C. trachomatis. Therefore, in these experiments I 
attempted to determine if the concentration of lactic acid and the pH of CVF could explain 
previous epidemiologic results. I found that the CVF of women with polymicrobial CSTs lacks 
significant lactic acid, and has too high a pH to be protective despite the presence of Lactobacilli 
spp. within these samples. The lowest pHs were observed in samples identified as CST I-CRISP, 
containing L. crispatus in agreement with H2O2 producing Lactobacilli spp. having the least risk. 
On the other hand, CST III-INERS samples, containing L. iners that does not produce H2O2 had a 
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broad pH range that overlapped with the pH range of both CST I-CRISP samples and 
polymicrobial samples. Strong correlations were observed between the pH and lactic acid 
concentration across all CSTs. The broad ranges of CST III-INERS, which extend into the ranges 
found for the polymicrobial samples confirm that there is a strong correlation between the 
epidemiologic studies and the acidity of CVF across different CSTs. Furthermore, these data 














Vaginal Bacteria Community State Types 
Advances in high-throughput sequencing allowed the entire vaginal microbiome to be 
characterized through sequencing of amplified 16S rDNA regions obtained from an entire 
community of vaginal bacteria. With this approach, the classifications of predominant 
Lactobacilli spp. and a polymicrobial community were both more clearly defined and further 
characterized by the variability within each. Three independent studies found that the vaginal 
microbiome is either polymicrobial, or represented by a single predominant Lactobacilli spp. 
that was either L. crispatus, L. iners, L. jensenii or L. gasseri (Hummelen et al., 2010; Ravel et al., 
2011; Spear et al., 2011). The nomenclature and breakdown of Community System Types (CSTs) 
provided by Ravel et al. (2011) has largely been adopted by the field. Specifically, vaginal 
samples were identified as one of 5 bacterial CSTs. CSTs I, II, III and V were represented by a 
predominant Lactobacilli spp. and CST IV was characterized by both the absence of a 
predominant Lactobacilli spp. and a polymicrobial array of gram-negative species of bacteria, 
including G. vaginalis which has long been associated with bacterial vaginosis (BV). In this 
document these names will be used to describe different vaginal CSTs, however, for simplicity 
the abbreviated name of the predominant bacteria will be included: CST I-CRISP, CST II-JENS, 
CST III-INERS, CST IV-POLY and CST V-GASS.  
Each of the independent 16S sequencing studies revealed that the four CSTs with a 
predominant Lactobacilli spp. are near monomicrobial (Hummelen et al., 2010; Ravel et al., 
2011; Spear et al., 2011). This was especially true for CST I-CRISP, CST II-JENS and CST V-GASS. In 
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these CSTs about 95% of bacterial sequence reads belonged to one species of Lactobacilli. CST 
III-INERS was similar, but had more additional species. 
Nugent scoring and vaginal bacterial community prevalence 
 As discussed in the introduction, estimates for the prevalence of BV, and by proxy the 
polymicrobial CSTs, relied on Nugent scoring. Nugent scoring attempts to distinguish BV by a 
lack of Lactobacilli morphotypes and the presence of BV-associated bacteria morphotypes 
(Nugent et al., 1991). It is calculated as the sum of scores associated with the presence or 
absence of these bacteria inferred by morphology. The score includes the amount of 
Lactobacilli or gram-positive rods, and the amount of BV-associated bacteria which are gram-
negative. The presence or absence of Mobiluncus spp. also contributes to the score, although 
the utility of this is less clear today. Using Nugent scoring the largest BV prevalence study to 
date found that 29% of women in the United States had BV, as diagnosed by a Nugent score of 
7-10 (Kenyon et al., 2013; Koumans et al., 2007). An additional 33% of women were labeled 
“intermediate” with a Nugent score of 4-6, and the remaining 38% were labeled “healthy” with 
a Nugent score less than 4.  
A Nugent score of 4-10 would require the presence of more than just Lactobacilli 
morphotypes, but Lactobacilli dominated CSTs are usually near monomicrobial. Therefore, 
under our current understanding of vaginal bacteria CSTs, we would expect women with a 
Nugent score of 4-10, or 62% of US women (Koumans et al., 2007) to be polymicrobial. A 
potential exception to this may be L. iners. Unlike the other vaginal Lactobacilli spp. L. iners 
despite being gram-positive, is frequently gram-negative in appearance (unpublished 
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observations). Therefore, some number of samples scored as intermediate or BV by Nugent 
score, may actually contain high concentrations of L. iners that are morphologically more 
similar to BV-associated bacteria and misidentified. Women with a Nugent score of 0-3, or 29% 
of US women, likely have a Lactobacilli-dominated CST, as a score that low requires a 
predominance of Lactobacilli morphotypes and little else. 
Community State Type stability and transitioning 
 CSTs are relatively stable, although a transition is most likely to occur before ovulation 
or before menses when estrogen levels are low (Gajer et al., 2012). These transitions have been 
well documented (Brotman et al., 2010), and certain CSTs transition to others at different rates 
(Gajer et al., 2012). Broadly speaking, Lactobacilli dominated CSTs are more stable than the 
polymicrobial community. CST III-INERS is the most likely CST to transition to CST IV-POLY. CST 
III-INERS also transitions to CST I-CRISP, but at a lower rate. CST I-CRISP, however, is not very 
likely to transition to CST IV-POLY, and transitions to CST III-INERS more frequently than any 
other CST. Taken together, this strongly suggests that the bacteria present in the different CSTs 
create a vaginal environment that is more hospitable to a specific subset of bacteria from other 
CSTs. 
Risk Factors Associated with Vaginal Bacterial Communities 
Although Nugent scoring only identified about one-third of women as having BV, it is 
important to note that most epidemiological studies have shown that the risk of STI infection 
associated with BV extends beyond women with a Nugent score of 7-10 and includes women 
who are “intermediate” with a Nugent score of 4-6 (Cohen et al., 1995; Martin et al., 1999). 
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Therefore the risk association is not limited to BV but to any vaginal bacterial community where 
Lactobacilli spp. are not predominant, as determined by Nugent scoring. Despite Nugent 
scoring only identifying 29% of the United States as having BV, the risk of STI acquisition would 
apply to the remaining 62% of women. 
Higher acidity is likely to be superior at inactivating STI pathogens 
It is likely that the risk of STI infection associated with a polymicrobial vaginal 
community is due to the lack of lactic acid compared to women with a Lactobacilli dominated 
vaginal community. This agrees with the dose-dependent microbicidal activity of lactic acid 
against HIV (Aldunate et al., 2013), C. trachomatis (Gong et al., 2014) and HSV (Conti et al., 
2009), as well as with the association of risk with any vaginal bacterial community where 
Lactobacilli spp. are not predominant. 
Physiological differences in CVF between vaginal CSTs 
 Surprisingly, few studies that incorporate 16S sequencing have attempted to identify 
correlative physiological differences in the CVF of women with different vaginal CSTs, opting 
instead for associations with health risks. Two studies that did compare the CVF between 
women with different CSTs assayed the vaginal glycogen content in CVF (Mirmonsef et al., 
2014) and the ability of the CVF to trap HIV particles (Nunn et al., 2015). Glycogen levels were 
found to be highest in samples that were identified as CST I-CRISP or CST III-INERS as opposed 
to CST IV-POLY, and CST I-CRISP had a higher concentration than CST III-INERS. HIV trapping was 
achieved in CST I-CRISP, but not CST III-INERS or CST IV-POLY. 
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Most surprisingly, even differences in the pH and lactic acid concentration between 
different vaginal CSTs have not been thoroughly investigated. Ravel et al. attempted to 
compare the average pH of the CVF in the different CSTs, however, their pH assay did not allow 
for measurements below 4.0 (2011). Even with this limitation, they observed that CST III-INERS 
had a higher average pH than CST I-CRISP. Mirmonsef et al. (2014) and Nunn et al. (2015) both 
supported and disagreed, respectively, with the finding that CST III-INERS had a higher average 
pH than CST I-CRISP. Only Nunn et al. (2015) measured the lactic acid content, and found it was 














I: Within Lactobacilli dominated communities are some Lactobacilli spp. more likely to offer 
protection than others? Does STI acquisition risk correlate with vaginal acidity? 
If the risk of STI infection is due to a lack of lactic acid, and women who lack H2O2 
producing bacteria are at a higher risk, I expected women in CST I-CRISP or CST II-JENS, 
characterized by the predominance of H2O2 producing L. crisptatus or L. jensenii, respectively, 
to have a lower pH and higher lactic acid concentration than CST III-INERS or CST V-GASS, which 
are characterized by L. iners and L. gasseri which do not produce H2O2.   
II: Do lactic acid concentrations and pH values of specific communities offer insight into how 
community transitions occur? 
As discussed previously in this dissertation, lactic acid is sufficient to inactivate 
polymicrobial vaginal communities. Therefore, if different CVF lactic acid concentrations are 
observed between different CSTs, it may provide evidence for why certain CSTs are more likely 
to switch to others. Specifically, given that CST III-INERS is most likely to switch to a 
polymicrobial CST, I expected that the lactic acid concentration of CST III-INERS CVF samples 
would be lower than the other Lactobacilli-dominated CSTs. 
III: Beside pH and the concentration of lactic acid, are there physiological differences between 
CVF from women with different vaginal CSTs? 
 Few studies have approached variation in CVF with an eye toward bacterial CSTs, 
despite the variability of risk observed between different CSTs. Therefore, in association with 
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measuring the acidity of CVF samples that were to be included in a 16S sequencing dataset, we 















Materials & Methods 
Sample collection and processing 
Voluntary donors were recruited at the Baltimore Druid Hill Health Clinic by cooperating 
medical staff. All CVF samples were self-collected by donors by inserting and removing an 
Instead® SoftCup menstrual collection device (Boskey et al., 2003). Softcups were placed in 50 
mL conical tubes and centrifuged to collect the CVF. Vaginal swabs were also self-administered 
and stored at -20°C before being used for 16S RNA community sequencing. The weight of each 
CVF sample was determined. Depending on the size of the sample it was allocated into separate 
tubes for the lactic acid concentration, protein concentration and osmolality measurements, 
and stored at -80°C. All samples were gram stained and observed under the microscope to 
assign a Nugent score (Nugent et al., 1991). 
16S RNA community sequencing 
 16S sequencing was performed by the Institute for Genome Sciences (IGS), University of 
Maryland in accordance with their previously published methods (Gajer et al., 2012). Briefly, 
genomic DNA extracted from frozen vaginal swabs was used for PCR amplification of the V1-V2 
region of the 16S RNA gene. Purified amplicons were sequenced by 454 pyrosequencing, and 
quality control of sequence reads was performed with QIIME (Caporaso et al., 2010). The 
Taxonomic assignments were made with a combination of the Ribosomal Database Project 
(RDP) Classifier (Wang et al., 2007) and speciateIT. We thank Jacques Ravel for extending the 
services of the IGS to our study. 
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Data analysis and CST Assignments 
 Samples were excluded from analysis if the total number of reads was less than 600. The 
dataset was then rarefied in R, using the lowest number of reads for any given sample, 1061, 
and read counts were converted to the log of the fraction of the total number of reads per 
sample. 
 CST assignments were made in R, using the methods described in (DiGiulio et al., 2015). 
Breifly, principal component analysis and the gap statistic function from the R stats cluster 
package were used to estimate the number of CSTs (Maechler et al., 2016). The analysis 
revealed 4 clusters, and clustering was performed using the partitioning around medioids 
algorithm (Maechler et al., 2016). The four resulting CSTs were named in accordance with Ravel 
et al. (2011), including grouping both polymicrobial CSTs into the singular CST IV-POLY. The R 
stats platform ggplot2 (Wickham, 2009) was used to generate the heatmap of the data. 
Measuring the pH, the lactic concentration, the protein concentration and the osmolality in 
CVF 
Measurements of pH were made with a microelectrode, in whole CVF before freezing. 
Measurements were not made under hypoxic conditions, or in the presence of 5% CO2. The 
lactic acid concentration of CVF supernatants was measured using the D-lactic acid/L-lactic acid 
Enzymatic BioAnalysis/Food Analysis UV method kit (R-Biopharm, Darmstadt, Germany) and a 
plate spectrometer. Typically samples were diluted 1:30 for the signal to be in the linear range 
of the spectrometer. The protein concentration of CVF supernatants was measured using the 
Thermo Scientific Pierce BCA Protein Assay Kit and a plate spectrometer. Typically samples 
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were diluted 1:50 for the signal to be in the linear range of the spectrometer. Osmolality 
measurements were made using undiluted CVF supernatant and a VAPRO® 5520 vapor 















Bacteria Community Assignments 
35 vaginal swabs and CVF samples were obtained from patients of the Baltimore City 
Druid Hill Clinic. The vaginal swabs were used for 16S RNA sequencing and cluster analysis was 
used to assign CSTs to each sample (Fig 7). The samples were clustered according to the 
fraction of reads that could be assigned to a specific bacterial species. Unlike Ravel 2011, CST II-
JENS and CST V-GASS were not observed in our sample set. As these CSTs are the least 
represented in their dataset we expect this is due to the lower number of samples. 
As can be seen, CST I-CRISP was heavily predominated by L. crispatus and very few other 
species. CST III-INERS was similar with the predominant L. iners, however, the BV-associated G. 
vaginalis was more highly represented in each of these samples compared to CST I-CRISP. 
Although, CST IV-POLY lacked a predominant Lactobacilli spp., L. iners was still detected in the 
majority of these samples, while other Lactobacilli spp. were not. 
Vaginal acidity greatly varies between different CSTs 
 The epidemiological data claims that both polymicrobial communities and Lactobacilli 
dominated communities that lack H2O2 producing Lactobacilli, are at a higher risk for STI 
acquisition. It is unlikely that this is due to the production of H2O2 (O’Hanlon et al., 2011). 
Instead, given the broad microbicidal activity of lactic acid, differences in vaginal acidity likely 
correlate with elevated risk for STI acquisition. Using the CST assignments, vaginal acidity 
comparisons were made between the different vaginal communities (Fig 8). Not surprisingly, 
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the lowest vaginal acidity was observed in CST IV-POLY. The pH of CST IV-POLY samples ranged 
4.61-5.51 with a mean pH of 5.06 ± 0.27. The lactic acid concentration in CST IV-POLY samples 
ranged 1.6-6.8 g/L with a mean concentration of 3.8 ± 1.4 g/L. The highest vaginal acidity was 
observed in CST I-CRISP. The pH of CST I-CRISP samples ranged 3.75-4.24 with a mean pH of 
3.95 ± 0.19. The lactic acid concentration in CST I-CRISP samples ranged 8.8-14.1 g/L with a 
mean concentration of 10.5 ± 2.3 g/L. Interestingly, an intermediate vaginal acidity was 
observed in CST III-INERS. The pH of CST III-INERS samples ranged 4.09-5.46 with a mean pH of 
4.68 ± 0.40. The lactic acid concentration in CST III-INERS samples ranged 1.9-9.8 g/L with a 
mean concentration of 5.4 ± 3.1 g/L. The wide range of acidity observed in CST III-INERS 
samples overlapped with both CST I-CRISP and CST IV-POLY. Two of the CVF samples assigned 
to CST III-INERS did not have a plurality of L. iners, but G. vaginalis instead (Fig 7). Importantly, 
these two samples are not the maxima of either the pH or lactic acid concentration range. 
Plotting the pH as a function of the lactic acid concentration in all CVF samples reveals a clear 
correlation (Fig 9), while visually revealing the wide range of vaginal acidity observed in CST III-
INERS samples that extends from CST I-CRISP samples to CST IV-POLY samples.  
Nugent scoring discriminates between Lactobacilli that produce high concentrations of lactic 
acid and bacteria that produce low concentrations of lactic acid 
Nugent scoring was highly discriminant of bacterial communities CST I-CRISP and CST IV-
POLY, but not CST III-INERS (Fig 10). All CST I-CRISP samples were considered healthy by Nugent 
score (0-3), while all CST IV-POLY samples were considered intermediate or BV-positive (4-10). 
Three of the CST III-INERS samples were assigned healthy Nugent scores, while the other five 
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were assigned intermediate or BV-positive scores. Interestingly, the healthy CST III-INERS 
samples contained the highest concentrations of lactic acid and had the lowest pH values within 
CST III-INERS and are observed clustering in the lower right with the CST I-CRISP samples in the 
lactic acid vs pH plot (Fig 9). 
Variations in epithelial cell shedding rate, protein concentration and osmolality do not 
correlate with specific vaginal CSTs 
In the previous chapter I presented a model for how vaginal epithelial shedding could 
select for specific species of bacteria. As an approximation of the shedding rate we estimated 
the total number of epithelial cells in the CVF samples. Despite a previous report that BV 
individuals shed epithelial cells at a higher rate (Gilbert et al., 2013), we observed no difference 
in the total number of epithelial cells per CVF sample across the different communities (Fig 11). 
Importantly, Gilbert et al. measured the number of cells per field of view and did not take into 
account variation in the volume of CVF. It should also be noted that our analysis was limited 
given a large number of samples with too low of a volume to perform the analysis. 
CVF protein concentration is a common normalization tool for comparing CVF from 
different donors, however, to our knowledge it has not been determined if protein 
concentration varies with bacterial community. We saw no significant difference in mean 
protein concentration between the different bacterial communities with a mean concentration 
of 2.8 ± 1.8 g/L across all the samples (Fig 12). Similarly, no significant difference was observed 
in the mean osmolality for the different bacterial communities, with a mean value of 450 ± 68 
mOsm (Fig 13), however, the range of osmolality extended much higher in CST IV-POLY samples 
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than in CST I-CRISP or CST III-INERS. Osmolality measurements in CST III-INERS samples may in 
fact represent a trend toward increased osmolality for this CST, however, with the limited 
number of samples the difference between the osmolality of CST I-CRISP CVF samples and CST 
















These results strongly suggest that the risk for STI acquisition associated with a 
polymicrobial community or a predominant Lactobacilli spp. that does not produce H2O2 can be 
explained by low levels of lactic acid. Across the 35 individuals we sampled, I observed the 
lowest acidity in CVF assigned to the polymicrobial CST IV-POLY, the highest acidity in CVF 
assigned to CST I-CRISP, characterized by H2O2 producer L. crispatus, and intermediate acidity in 
CVF assigned to CST II-INERS, characterized by L. iners which does not produce H2O2. Only the 
acidity of CVF obtained from women with CST I-CRISP was similar to the range of acidity that we 
and others have shown can inactivate HIV, C. trachomatis and HSV (Aldunate et al., 2013; Conti 
et al., 2009; Gong et al., 2014). Only the most acidic CVF samples observed in CST I-INERS and 
CST IV-POLY may be protective for BV-associated bacteria given our previous in vitro data 
(O’Hanlon et al., 2011). Even this is unlikely, however, as in the previous chapter I reported less 
inactivation of BV-bacteria by more acidic samples ex vivo than what was demonstrated in vitro.  
The range of the pH in CST IV-POLY and CST I-CRISP did not overlap, and only one CST I-
CRISP sample had a lactic acid concentration that overlapped with the range of CST IV-POLY. 
Given that the protections are thought to be due to a high lactic acid concentration and low pH, 
it is unlikely that a woman with a polymicrobial community would have the benefits that lactic 
acid can provide. The converse of this, however, that a community dominated by Lactobacilli 
spp. is always protective is not true. Three of the CST III-INERS samples were in the same acidity 
range as CST I-CRISP and three were not. Therefore, although Lactobacilli are likely necessary to 
reach high enough concentrations of lactic acid to provide protection, not all Lactobacilli spp. 
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are capable of sufficient acidification. Furthermore, our data suggest more variability among 
strains of L. iners, some of which acidify more and would be expected to be more protective 
than others. Samples that received a Nugent score of 4-10 were not restricted to CST IV-POLY. 
Instead, the same five CST-INERS samples that were less acidic were also given elevated Nugent 
scores. Inspecting these slides again revealed that the morphology and density of these L. iners 
strains was more similar to the morphology of BV-associated bacteria than other Lactobacilli 
spp. We can conclude that most women with a Nugent score of 4-10 have a vaginal bacterial 
community that fits CST IV-POLY. However, a Nugent score of 4-10 likely contains a small subset 
of women that fall into CST III-INERS. Furthermore, although Nugent score may not be reliable 
in distinguishing between CST IV-POLY and CST III-INERS, it may be adequate to predict risk, as 
the high Nugent score CST III-INERS samples were the least acidic. 
Interestingly, Mirmonsef et al., who also observed higher pH values in CST III-INERS than 
in CST I-CRISP, demonstrated that the glycogen concentration in the CVF is highest for CST I-
CRISP, lowest for CST IV-POLY and intermediate for CST III-INERS (2014). Although the authors 
hypothesized that glycogen levels may influence which strains of bacteria can colonize the 
vagina, it is also possible that high glycogen levels reflect a slow growing population of bacteria 
with a low metabolic demand. Taking into account the findings of the second chapter of this 
thesis, which demonstrate that Lactobacilli slow their growth rate in a more acidic 
environment, we would expect CST I-CRISP bacteria to grow slower than CST III-INERS bacteria, 
given the disparate pH.  
Although lactic acid has long been thought to originate from Lactobacilli, little 
information has been provided to show the amount of lactic acid and the degree of acidity in 
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the absence of lactobacilli. Interestingly, the concentration of lactic acid in CST IV-POLY CVF 
samples was roughly 50-fold higher than the normal range of lactic acid in serum (Mizock and 
Falk, 1992). This suggests that even in the absence of a predominant Lactobacilli spp. lactic acid 
is accumulating in the vagina. It is possible some lactic acid is produced by the bacteria within 
CST IV-POLY, however, it is also possible that the lactic acid comes from the host epithelium. 
This may reflect a higher rate of anaerobic metabolism in the epithelium, given the hypoxic 
environment of the vagina. 
 Given that high vaginal concentrations of lactic acid and a low vaginal pH can effectively 
prevent the growth of BV-bacteria, these results also illuminate a possible mechanism by which 
BV bacteria could succeed in colonizing a Lactobacilli dominated vagina. Vaginal lactic acid is 
sufficient to inactivate BV-bacteria, however, even Lactobacilli are eventually inactivated by a 
high enough lactic acid concentration and low enough pH. Lactobacilli that acidify the vagina to 
a similar pH would be unable to inactive the other bacteria through the production of lactic acid 
alone. Given the wide range of pH and lactic acid concentrations associated with CST III-INERS it 
remains plausible that this CST could represent a transition point between a Lactobacilli 
dominated community and a polymicrobial community. This idea is in agreement with Gajer et 
al. which reported that transitions between a Lactobacilli dominated community and a 
polymicrobial community are more commonly from L. iners than from the other Lactobacilli 
species (2012). Furthermore, the only Lactobacilli spp. typically present in a CST IV-POLY is L. 
iners. 
 The osmolality of CVF is surprisingly higher than the normal range maintained in the 
body 270-300 mOsm/kg. Although an explanation for this remains unclear, it was true in each 
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CST. The increased concentration of bacteria observed in polymicrobial communities may cause 
a higher concentration of bacterial metabolites. Interestingly, the highest osmolarities were 
observed in CST IV-POLY. A high CVF osmolality may be responsible for watery discharge, which 
is a historic symptom of BV (Amsel et al., 1983). Not all women with BV report vaginal discharge 
as a symptom, which may reflect the low number of these samples in our dataset. Although 
















Figure 7—CST assignments and heatmap of 35 CVF samples 
Heatmap of log representation of each bacterial species within a CVF sample. Each horizontal 
line represents a different donor. Donors are ordered by CST, indicated by the CST assignments 









Figure 8—Measured pH across different CSTs 
The pH under standard laboratory conditions (non-hypoxic) (A) and lactic acid concentrations 
(B) of the CVF samples organized by CST. Solid horizontal lines indicate the means of the 
populations. 
 














































Figure 9—The lactic acid and pH of CVF samples correlates across all CSTs  



















Figure 10—Nugent scoring can identify CST IV-POLY and CST I-CRISP but not CST III-INERS 























































Figure 11—The average number of epithelial cells in CVF does not vary with CST 
The estimated total number of epithelial cells per CVF sample organized by CST. Solid horizontal 



















































Figure 12—The average protein concentration of CVF does not vary with CST 
The protein concentration of CVF samples organized by CST. Solid horizontal lines indicate the 




























Figure 13—The average osmolality of CVF does not vary with CST 
The osmolality of CVF samples organized by CST. Solid horizontal lines indicate the means of the 
populations. Note that in all three communities the CVF was markedly hyperosmolal with 
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Host antibody coating of vaginal bacteria and its 
implications 
Chapter abstract 
Gut bacteria are labeled with IgA and IgG antibodies, but to date, few attempts have been 
made to identify antibody labeling of vaginal bacteria, despite the increasing importance of 
these antibodies in maintaining gut bacterial communities. In these experiments I demonstrate 
that vaginal Lactobacilli are labeled by both IgG and IgA host antibodies using an 
immunofluorescent approach. Quantification of the fluorescent intensity was performed using 
image analysis of microscopic images, before successfully using flow cytometry to analyze the 
labeling. Both approaches reveal that the majority of vaginal Lactobacilli are labeled with host 
IgG and IgA and that in the majority of samples IgA labels more intensely than IgG. Although 
these experiments do not prove that the labeling is highly specific, a small subset of cultured 
bacteria from CVF could be recoated with dilute CVF supernatant, and had similar fluorescent 
intensity after staining. These experiments reveal a novel feature of vaginal bacteria that makes 
them more similar to gut bacteria than previously thought, and demonstrate the usefulness of 






Gut surveillance of bacteria 
 Surveillance of gut bacteria is carried out primarily by Peyer’s Patches, which are part of 
the Gut Associated Lymphoid Tissue (GALT) (Hamada et al., 2002; Mowat, 2003). Within the 
Peyer’s Patches, M-cells, specialized intestinal epithelium cells, translocate bacteria from the 
lumen and deliver them to Antigen Presenting Cells (APCs). These APCs, specifically the motile 
Dendritic Cells (DCs), carry the bacteria to the mesenteric lymph nodes. The DCs then activate a 
number of other immune cells including B-cells. Activated B-cells home back to the mucosa and 
secrete IgA (Craig and Cebra, 1971), which is translocated back across the epithelium into the 
lumen. 
B-cell homing and antibody secretion 
 Bacteria that are translocated by M-cells are confined to the mesenteric lymph nodes, 
and activated B-cells only home primarily to the mucosa. In this way the immune response is 
not systemic, and only results in the secretion of IgA across the mucus membrane (Johansen, 
2005), preventing antibody secretion in the serum (Craig and Cebra, 1971). B-cells do not only 
home back to the gut, although a comprehensive list of other sites along the mucosa, such as 
the vagina, has not been established. In both rats and humans it has been shown that a nasal 
immune response leads to B-cell homing to the vagina (Pierce and Gowans, 1975), or antigen 
specific IgA secretion (Johansen, 2005). Furthermore, gut inoculation has led to the secretion of 
IgA and IgG into the respiratory tract of mice (Zuercher et al., 2002).  
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The function of antibodies in mucosal immunity 
The function of IgA is complex (Macpherson et al., 2008; Mantis et al., 2011). Gut 
bacteria are extensively labeled by IgA and IgG, however, IgA appears to preferentially label 
commensal bacteria and may lead to pathologies such as Crohn’s disease or irritable bowel 
syndrome when it labels pathogenic bacteria instead (Palm et al., 2014). The benefits of 
labeling are thought to include preventing the bacteria from crossing the intestinal epithelium, 
preventing bacteria from activating immune cells and potentially providing labeled bacteria a 
selective advantage. Specifically it has been shown that IgA labeling of bacteria enhances their 
ability to form biofilms and adhere to an epithelium in vitro (Bollinger et al., 2006).  
It is possible that antibodies in the gut prevent bacteria from crossing the intestinal 
epithelium by trapping the bacteria in the mucus. This has been observed in the vagina with 
sperm (Castle et al., 1997), HSV and in the mouse gut with Salmonella thyphimurium (Wang et 
al., 2014). In these experiments, the presence of specific antibodies tethers their target to the 
mucus. The exact mechanism behind this is unclear, but it is likely mediated by weak transient 
reversible bonds between antibody Fc regions and mucin fibers. 
 Despite immunoglobulin being the second most concentrated protein within CVF 
(Panicker et al., 2010), it is unknown if it plays any role in the dynamics of vaginal bacterial 
communities. The high concentration of immunoglobulin potentially originates from the blood 
serum via interstitial fluid. This is supported by a similar 1:5 IgA to IgG ratio observed in both 
vaginal mucus and serum (Chipperfield and Evans, 1975; Gonzalez-Quintela et al., 2007; Wang 
et al., 2014), however, the total concentration of antibody in CVF is also about 50-fold lower 
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than in serum. The other possibility is that the immunoglobulins are secreted by immune cells 
that have homed to the vagina. One could imagine how the presence of certain gut bacteria 
could affect the survival of certain species in the vagina. If secreted IgA label a subset of the 
vaginal bacteria it could promote the survival of these species by allowing them to avoid 
detection by the immune system, or in the case of G. vaginalis could prove instrumental in its 
ability to form a biofilm. 
Non-vaginal strain oral probiotics support vaginal Lactobacilli 
 Probiotic approaches to treat BV have had mixed success (Falagas et al., 2007; 
Homayouni et al., 2014; Senok et al., 2009). There is no evidence that oral probiotics provide 
long-term treatment of BV, however, it seems there is a short-term change in the composition 
of the vaginal microbiota (Macklaim et al., 2015; Reid et al., 2003; Vujic et al., 2013). Although 
this is likely not efficacious for the treatment of BV, it may provide clues as to how a vaginal 
microbiota is maintained by the host. Specifically, there is evidence that oral administration of 
non-vaginal Lactobacilli spp. leads to an increase in the concentration of Lactobacilli within the 
vagina (Macklaim et al., 2015). The vaginal tract is not connected to the digestive tract, and the 
evidence to date has failed to detect significant amounts of gut bacteria in the vagina. 
Therefore, it is not surprising that the Lactobacilli spp. within the probiotic are not the species 
that appear within the vagina. Instead, vaginal Lactobacilli spp., usually L. iners, become more 
abundant. This suggests a connection between bacteria present in the gut, and the 
permissibility of the vagina to specific strains of bacteria. It is possible that this connection is 
maintained by the mucosal immune system. 
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Research Goals 
I: Can host IgA or IgG antibodies be identified on vaginal bacteria? 
The vaginal immunoglobulins are either being secreted into the CVF by immune cells, or already 
present in the interstitial fluid that is deposited into the vagina. In either case the high 
concentration of immunoglobulins may coat vaginal bacteria. Given the importance of antibody 
coating bacteria in the gut, it was paramount to establish whether vaginal bacteria are coated 
as well. Boskey reported pilot observations that suggested vaginal bacteria are coated in the 
appendix of her Biophysics PhD thesis (2000). To confirm and quantify her pilot observations, I 
used both a microscopic and flow cytometry to detect and quantify antibodies on the surfaces 
of ex vivo vaginal bacteria. 
II: Can vaginal bacteria be cultured and recoated with host antibody? 
The observation of host antibodies on vaginal bacteria cannot confirm the specificity of the 
antibodies to the bacteria. Understanding if the antibody binding is specific is important for 
understanding how the antibodies might affect the vaginal community, as well as where they 
are originating. To approach this question I used cultured antibody free vaginal bacteria from 






Materials & Methods 
CVF collection and processing 
All CVF samples were self-collected by donors by inserting and removing an Instead® 
SoftCup menstrual collection device (Boskey et al., 2003). Softcups were placed in 50 mL conical 
tubes and centrifuged to collect the CVF. A slide was made for each sample to assign a Nugent 
score. For microscopy experiments CVF was mixed with FITC conjugated 0.5 µm diameter 
fiduciary beads before being pipetted onto a glass slide and allowed to briefly dry before being 
washed three times with PBS. For flow cytometry experiments, CVF diluted 1:10 was passed 
spun through a 10 µm cell strainer to remove epithelial and immune cells. The filtered bacteria 
were pelleted by centrifugation and washed three times with PBS. 
For recoating experiments an aliquot of the original CVF sample diluted 1:10 in saline 
was centrifuged and the collected supernatant was sterile filtered using 0.2 µm spin filters. 
Sterile dilute supernatants were stored at -80°C before being thawed for recoating 
experiments. 
Antibody labeling 
Alexa488 conjugated Goat anti-human IgA, IgG or IgM F(AB)s were diluted in PBS 1:400 
and incubated with ex vivo unfixed bacteria either mounted on slides for microscopy, or in 
solution for flow cytometry. F(AB) incubations were at room temperature and lasted 30 
minutes. Afterward PBS washes were applied directly to the slide, or the bacteria in solution 
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were rinsed by spinning down, aspirating and resuspending in PBS three times. Hoechst 
solution was added to the bacteria on the slides to stain for DNA. 
Microscopy and quantification 
Bacteria were visualized using the Zeiss Axiovert 200 inverted lighted microscope, and 
images were recorded at 100x magnification. Bacteria were identified by DNA staining, and 
fluorescent intensity measurements of individual bacteria were made in ImageJ. The fiduciary 
beads that were mounted on the slide along with the bacteria, were used to normalize 
fluorescent intensity measurements. 
Flow cytometry 
 Flow cytometry was performed on the BD FACSCanto using BD FACSDiva software. 
Before running bacterial solutions on the instrument, samples were pipetted over a 35 µm cell 
strainer. Bacterial populations were identified and gated based on their location in forward 
scatter and side scatter area plots. The FITC intensity of at least 1000 gated events was 
recorded per run. The instrument was calibrated using FITC conjugated beads to allow for 
fluorescent intensity comparisons between different experiments. FCS files were converted into 
CSV files and data manipulation and graphing was performed in R. 
Bacteria culturing and recoating 
 To obtain antibody free bacteria, CVF samples were plated on Brucella broth, 5% sheep 
blood plates. Blood plates were incubated at 37°C in anaerobic jars with oxygen scavenger 
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sachets. After 2-3 days of incubation, bacterial colonies were scraped off the plate, vigorously 
resuspended in saline, and rinsed three times with PBS.  
To recoat cultured bacteria with antibody, the bacteria were incubated in suspension 
with either the sterile filtered dilute supernatant obtained from the original CVF sample or PBS 
for one hour at room temperature. After incubation the bacteria were rinsed three times in 














Host antibodies can be visualized on vaginal Lactobacilli 
Given the high concentration of Immunoglobulins (Ig) in the gut I wanted to determine if 
vaginal bacteria were labeled by these host antibodies. Utilizing a microscopy approach I 
treated CVF samples obtained from women with a Nugent score less than 4 with fluorescently 
labeled anti-human Ig F(AB). Anti-human Ig F(AB) was used instead of complete Igs to rule out 
the possibility of the secondary antibodies being recognized by Fc-receptors on the bacteria. In 
all samples tested I observed significant labeling of the vaginal bacteria with both F(AB) anti-IgG 
and F(AB) anti-IgA, confirming the presence of host IgG and IgA antibodies on the bacteria (Fig 
14). F(AB) anti-IgM had very limited labeling compared to the other two. For most donors the 
majority of bacteria appeared to be labeled with IgA and IgG (data not shown). Individual 
bacterial fluorescence was quantified by measuring the fluorescence of each bacteria and 
normalized to fiduciary beads imaged along with the bacteria. In all but one of the samples the 
staining of anti-IgA exceeded that of anti-IgG, despite IgG being more concentrated than IgA in 
CVF (Fig 15). To verify that bacteria could not bind F(AB)s through an unknown mechanism, I 
also labeled the bacteria with anti-Mouse IgG. No significant staining was observed (data not 
shown). I also used the microscopy based approach to detect whether antibodies coat bacteria 





Flow Cytometry can be used to quantify coating by host antibodies 
 Due to both the cumbersome nature of microscopy based quantification as well as the 
limited number of bacteria included in the analysis, I adapted flow cytometry protocols to 
better quantify the degree of host antibody labeling in CVF samples. Samples were prepared 
similarly as to the microscopy experiments, and then analyzed by flow cytometry to measure 
the fluorescence of individual bacteria. Significant labeling by anti-IgA and anti-IgG was 
observed in nearly all 5 samples that vastly exceeded the labeling of anti-IgM (Fig 16). Nearly all 
of the bacteria were labeled by IgA and/or IgG, as compared to the fluorescent intensities of 
control, unlabeled bacteria. In 4 of the 5 samples the median fluorescent intensity of bacteria 
labeled with anti-IgA labeled was higher than anti-IgG (Table 1). Although in samples such as 
HA08 and HA14, clear bimodal distributions could be observed and are not easily described by a 
median measurement. Overall, the flow cytometry based approach greatly corroborated the 
microscopy based approach, confirming the presence of host antibody labeling of vaginal 
Lactobacilli, and validating its use as a tool. 
Vaginal bacteria can be recoated by host antibodies after being grown in culture 
 The presence of host antibodies on vaginal bacteria could be due to specific antibody 
recognition of the vaginal bacteria, or nonspecific given the long period of time the bacteria 
spend exposed to a high concentration of antibody. To rule out this possibility I obtained host 
derived antibody free bacteria, by culturing CVF samples on agar plates, and resuspending the 
colonies in saline. Although a vaginal bacterial community predominated by Lactobacilli spp. 
tends to be monomicrobial, there could still be intrastrain variability. This approach may 
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overestimate the presence of fast growing bacteria compared to slow growing bacteria in the 
final solution, but it should also preserve some of the community diversity. 
 Cultured bacteria were treated with either PBS, or the supernatant obtained from the 
original CVF sample, diluted 10-fold. PBS treatment did not result in staining. Only in the 
supernatant treated sample did anti-IgA and anti-IgG label the bacteria (Fig 17), however, only a 
fraction of the cultured bacteria were labeled, unlike the ex vivo uncultured bacteria. For one of 
the samples (K001) IgA and IgG labeled with very similar intensity to that of the uncultured 
bacteria, and for the other (HA04) only the brightest labeling returned (Fig 16). Despite variable 
staining, microscopic inspection of the cultured bacteria revealed a homogenous community of 












 Here I report that vaginal Lactobacilli are bound by host antibodies, similar to the 
bacteria in the gut. Nearly all of the vaginal Lactobacilli stained positive for host IgA and IgG if 
analyzed ex vivo, however, only a portion of the Lactobacilli that were cultured stained positive 
after exposure to CVF supernatant. Although microscopy revealed homogenous morphology 
amongst the stained bacteria, there could still be variation that leads to the expression of 
specific epitopes in a subset of bacteria that grows faster on the agar plates than the vaginally 
dominate strain. 
Regardless of the reduced staining, a population of cultured bacteria could be recoated 
by the dilute supernatant of the original CVF sample. Although one might attribute a reduced 
number of labeled bacteria to the reduced concentration of antibodies, the signal in cultured 
bacteria is similarly intense to the uncultured bacteria. This suggests the presence a population 
of antibodies within the CVF that specifically bind one or more vaginal strains of Lactobacilli. 
However, it is also possible that binding is mediated through some other mechanism such as Fc-
receptors, although, this would require only a subset of the vaginal bacteria to have Fc-
receptors. Furthermore, staining for IgA provided the most intense signal compared to IgG and 
IgM in most samples, despite IgA being significantly less concentrated than IgG in CVF 
(Chipperfield and Evans, 1975; Gonzalez-Quintela et al., 2007; Wang et al., 2014). If the binding 
was nonspecific one would expect labeling to correlate with the concentrations of the 
antibodies. 
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 The origin of the antibodies that label vaginal bacteria is still uncertain. Despite a lack of 
organized immune tissue in the vagina the bacteria might be surveyed by the immune system, 
leading to antibody secretion that is specific to the vaginal bacteria. Given the effect of an oral 
Lactobacilli probiotic on the vaginal bacterial community, another possibility is that the immune 
system detects bacteria at mucosal sites other than the vagina, but leads to antibody secretion 
in multiple sites, including the vagina. Even if the bacteria detected by the immune system were 
not vaginal strains of bacteria, closely related or similar bacteria could lead to the eventual 
secretion of antibodies that label vaginal bacteria. It is also possible that local surveillance and 
cross talk between body sites are dependent on the current vaginal bacterial community. 
Vaginal Lactobacilli L. crispatus and L. jensenii have been described as non-inflammatory to the 
vaginal epithelium, and through lactic acid production may in fact reduce inflammation 
(Aldunate et al., 2015), and limit the possibility of immune surveillance when these bacteria are 
present.  
 The discovery that vaginal bacteria are labeled by host antibodies is an important step 
to understanding how the host immune system may play a role in determining a vaginal 







Figure 14—Immunofluorescence reveals IgA and IgG staining of vaginal Lactobacilli 
Labeling of ex vivo vaginal Lactobacilli obtained from a CVF sample with a Nugent score less 
than 4 with anti-human IgA (top) and anti-human IgG (bottom). DNA staining reveals individual 










Figure 15—Fluorescent intensity distributions of antibody coated bacteria using image based 
quantification 
Microscopy based quantification of fluorescence intensity of individual bacteria labeled with 
fluorescently labeled anti-human IgA, IgG or IgM (A, G, M) in 6 different CVF samples with 











Figure 16— Fluorescent intensity distributions of antibody coated bacteria using flow 
cytometry  
Flow cytometry based distribution of fluorescence intensity of individual bacteria labeled with 
fluorescently labeled anti-human IgA, IgG or IgM in 5 different CVF samples with Nugent score 





Figure 17—Cultured bacteria from CVF samples can be recoated with antibodies from CVF 
supernatant 
Flow cytometry based distribution of fluorescence intensity of bacteria from CVF after 



















Table 1—The median intensity of IgA staining tends to be higher than IgG or IgM 
Median fluorescent intensity of bacteria analyzed by flow cytometry from 5 different donors 
and stained for IgG, IgA or IgM. 
 
  Median Fluorescent Intensity       
Donor  Unlabeled IgG IgA IgM 
      
K001  0 483 559 94 
HA04  0 161 199 0 
HA08  0 371 502 24 
HA14  0 417 253 26 
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